Enterprise Value
29.29M
Cash
203M
Avg Qtr Burn
-11.22M
Short % of Float
3.64%
Insider Ownership
0.96%
Institutional Own.
87.43%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
STAR-0215 Details Hereditary angioedema | Phase 1/2 Data readout |